Clinical Trial Update: Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating rituximab in addition to chemotherapy with autologous stem cell transplantation for poor-prognosis Diffuse Large B-Cell Lymphoma has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie | Conditions: Diffuse Large B-Cell Lymphoma, POOR PROGNOSIS | Phase 2 | Status: COMPLETED